Monitoring early fusion dynamics of human immunodeficiency virus type 1 at single-molecule resolution

被引:40
作者
Dobrowsky, Terrence M. [1 ,3 ]
Zhou, Yan [2 ,4 ,5 ]
Sun, Sean X. [1 ,2 ,3 ,6 ]
Siliciano, Robert F. [2 ,3 ,4 ,5 ]
Wirtz, Denis [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Howard Hughes Med Inst Grad Training Program, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA
[4] Johns Hopkins Med Inst, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA
[5] Johns Hopkins Med Inst, Sch Med, Dept Med, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA
关键词
D O I
10.1128/JVI.00053-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The fusion of human immunodeficiency virus type 1 (HIV-1) to host cells is a dynamic process governed by the interaction between glycoproteins on the viral envelope and the major receptor, CD4, and coreceptor on the surface of the cell. How these receptors organize at the virion-cell interface to promote a fusion-competent site is not well understood. Using single-molecule force spectroscopy, we map the tensile strengths, lifetimes, and energy barriers of individual intermolecular bonds between CCR5-tropic HIV-1 gp120 and its receptors CD4 and CCR5 or CXCR4 as a function of the interaction time with the cell. According to the Bell model, at short times of contact between cell and virion, the gp120-CD4 bond is able to withstand forces up to 35 pN and has an initial lifetime of 0.27 s and an intermolecular length of interaction of 0.34 nm. The initial bond also has an energy barrier of 6.7 k(B)T (where k(B) is Boltzmann's constant and T is absolute temperature). However, within 0.3 s, individual gp120-CD4 bonds undergo rapid destabilization accompanied by a shortened lifetime and a lowered tensile strength. This destabilization is significantly enhanced by the coreceptor CCR5, not by CXCR4 or fusion inhibitors, which suggests that it is directly related to a conformational change in the gp120-CD4 bond. These measurements highlight the instability and low tensile strength of gp120-receptor bonds, uncover a synergistic role for CCR5 in the progression of the gp120-CD4 bond, and suggest that the cell-virus adhesion complex is functionally arranged about a long-lived gp120-coreceptor bond.
引用
收藏
页码:7022 / 7033
页数:12
相关论文
共 64 条
[21]   Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites [J].
He, Y ;
Vassell, R ;
Zaitseva, M ;
Nguyen, N ;
Yang, ZN ;
Weng, YK ;
Weiss, CD .
JOURNAL OF VIROLOGY, 2003, 77 (03) :1666-1671
[22]   Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1 [J].
Ho, Siu-Hong ;
Martin, Francine ;
Higginbottom, Adrian ;
Partridge, Lynda J. ;
Parthasarathy, Varadarajan ;
Moseley, Gregory W. ;
Lopez, Peter ;
Cheng-Mayer, Cecilia ;
Monk, Peter N. .
JOURNAL OF VIROLOGY, 2006, 80 (13) :6487-6496
[23]   Free energy reconstruction from nonequilibrium single-molecule pulling experiments [J].
Hummer, G ;
Szabo, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :3658-3661
[24]   CALIBRATION OF ATOMIC-FORCE MICROSCOPE TIPS [J].
HUTTER, JL ;
BECHHOEFER, J .
REVIEW OF SCIENTIFIC INSTRUMENTS, 1993, 64 (07) :1868-1873
[25]   Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells [J].
Iyengar, S ;
Hildreth, JEK ;
Schwartz, DH .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5251-5255
[26]  
Jablonowski H, 2003, MMW Fortschr Med, V145 Spec No 1, P4
[27]   Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].
Kilby, JM ;
Hopkins, S ;
Venetta, TM ;
DiMassimo, B ;
Cloud, GA ;
Lee, JY ;
Alldredge, L ;
Hunter, E ;
Lambert, D ;
Bolognesi, D ;
Mathews, T ;
Johnson, MR ;
Nowak, MA ;
Shaw, GM ;
Saag, MS .
NATURE MEDICINE, 1998, 4 (11) :1302-1307
[28]   Mode of action of an antiviral peptide from HIV-1 -: Inhibition at a post-lipid mixing stage [J].
Kliger, Y ;
Gallo, SA ;
Peisajovich, SG ;
Muñoz-Barroso, I ;
Avkin, S ;
Blumenthal, R ;
Shai, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1391-1397
[29]   CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 [J].
Kozak, SL ;
Platt, EJ ;
Madani, N ;
Ferro, FE ;
Peden, K ;
Kabat, D .
JOURNAL OF VIROLOGY, 1997, 71 (02) :873-882
[30]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659